Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing the Efficacy of Dapagliflozin as a Vasculoprotective Treatment in Septic Shock Patients With Microcirculatory Dysfunction

NCT07488689 is registered in ClinicalTrials.gov with University Hospital, Strasbourg, France as lead sponsor.

NCT NCT07488689
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07488689 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing the Efficacy of Dapagliflozin as a Vasculoprotective Treatment in Septic Shock Patients With Microcirculatory Dysfunction
Lead sponsor
University Hospital, Strasbourg, France
Phase
Phase 3
Overall status
Not yet recruiting
Start date
July 31, 2026
Completion date
July 31, 2030
Enrollment
568 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

septic shock